JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266652

Human ZC3H15 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

ZC3H15 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human ZC3H15 knockout HEK-293T cell line (AB266652)
  • Sanger seq

Unknown

Sanger Sequencing - Human ZC3H15 knockout HEK-293T cell line (AB266652)

Homozygous : 1 bp insertion in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266652-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266652-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266652 Human ZC3H15 knockout HEK-293T cell line", "number":"AB266652-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266652-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266652-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266652 Human ZC3H15 knockout HEK-293T cell line", "number":"AB266652-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266652-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266652 Human ZC3H15 knockout HEK-293T cell line", "number":"AB266652-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266652-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266652 Human ZC3H15 knockout HEK-293T cell line", "number":"AB266652-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ZC3H15
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Zinc finger CCCH-type containing 15 (ZC3H15) is a small protein with a mass of approximately 70 kDa. The protein has an additional name NDP52 that arises from research in specific contexts of cell biology. ZC3H15 contains a zinc finger domain that binds RNA indicating its role in post-transcriptional regulation. The protein shows expression in multiple cell types but higher expression levels occur in immune cells reflecting its specialized functions in immunity and cellular signaling.
Biological function summary

ZC3H15 participates in the regulation of mRNA stability and degradation impacting gene expression dynamically. The protein acts as part of a ribonucleoprotein complex working together with other proteins to influence RNA processing events. ZC3H15 modulates innate immune responses by controlling the degradation and translation of mRNAs encoding inflammatory mediators. This regulation helps maintain cellular homeostasis during immune challenges.

Pathways

ZC3H15 plays significant roles in the NF-kB signaling and apoptosis pathways. It influences the NF-kB pathway by interacting with proteins that control inflammatory gene expression such as TRAF2 and TAK1. ZC3H15 affects the apoptotic pathway through its impact on mRNA stability altering the expression of key apoptotic regulators. These interactions showcase its functional importance in balancing cell survival and death decisions under stress and pathological conditions.

ZC3H15 has associations with autoimmune conditions and infectious diseases. Dysregulation of ZC3H15 can lead to excessive inflammation contributing to diseases like rheumatoid arthritis through mishandled NF-kB signaling. In infectious diseases the modulation of ZC3H15 expression links to viral pathology as certain viruses exploit this protein to evade immune responses. Exploring these connections could inform potential therapies targeting ZC3H15 or its associated pathways involving proteins like MAVS that play central roles in antiviral defense.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com